関連する実験動画
Updated: Feb 28, 2026

Isolation and Differentiation of Stromal Vascular Cells to Beige/Brite Cells
Published on: March 28, 2013
ADGRL4はAKT活性化を介して脂肪の褐色化と体重減少を誘導する
Longyun Hu1, Ze-Wei Zhao1, Qian Wu1
1Shenzhen Key Laboratory of Systems Medicine for Inflammatory Diseases & Department of Biochemistry, School of Medicine, Sun Yat-sen University, Shenzhen, 518107, China.
Abstract:
Brown and beige adipose tissues, which contain high levels of mitochondria and UCP1, are crucial for energy expenditure and metabolic homeostasis. Previous studies have established that G protein-coupled receptors (GPCRs) play a critical role in mediating adaptive thermogenesis and browning. While the β3-adrenoceptor (β3-AR) serves as the key β-adrenergic GPCR driving adipose thermogenesis in mice, its minimal presence in human adipocytes hinders its therapeutic application. This study identifies adhesion G protein-coupled receptor L4 (ADGRL4) as a potential GPCR target for inducing adipose browning. In vitro experiments demonstrated that ADGRL4 activation promotes beige adipocyte differentiation, significantly upregulates UCP1 expression, and reduces lipid droplet accumulation. In vivo, ADGRL4 activation induces the development of beige fat in mice fed a normal chow diet without causing systemic effects. In mice fed a high-fat diet, ADGRL4 activation reduces fat deposition, decreases body weight, alleviates glucose intolerance, and ameliorated obesity and associated metabolic dysfunction. Furthermore, mechanistic investigations revealed that ADGRL4 specifically enhances AKT phosphorylation without altering total AKT levels, thereby activating a downstream signaling cascade that elevates UCP1 expression. This coordinated regulation through the p-AKT/UCP1 axis substantiates the role of ADGRL4 in driving adipose browning and identifies it as a promising molecular target for the treatment of obesity and associated metabolic disorders.
さらに関連する動画
関連する概念動画
cAMP-dependent Protein Kinase Pathways
PI3K/mTOR/AKT Signaling Pathway
GPCRs Regulate Adenylyl Cylase Activity
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
Regulation of Food Intake

